BiotechTube
Home/Viatris/Riad El-Dada
RE

Riad El-Dada

EVP, Global General Counsel & Corporate Secretary

Viatris

Therapeutic Areas

CardiologyDermatologyImmunologyInfectious DiseasesCentral Nervous System DisordersOncologyRespiratory

Viatris Pipeline

DrugIndicationPhase
Biosimilar Adalimumab (Abrilada®)Chronic Inflammatory Diseases (e.g., RA, Psoriasis)Launched
Biosimilar BevacizumabMetastatic Colorectal Cancer, NSCLCLaunched
Biosimilar PegfilgrastimChemotherapy-induced NeutropeniaLaunched
Wixela Inhub (Fluticasone/Salmeterol)Asthma, COPDLaunched
Epinephrine Auto-InjectorAnaphylaxisFiled
YP-10PresbyopiaNDA Filed

Leadership Team at Viatris

SA
Scott A. Smith
Chief Executive Officer
SN
Sanjeev Narula
Executive Director & Chief Financial Officer
RM
Rajiv Malik
President
BH
Bridgette Heller
Chief Human Resources Officer
RJ
Robert J. Coury
Chairman of the Board
View full Viatris profile